ArticleCells2019

Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization.

Julia Schueler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.